For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220223:nRSW4852Ca&default-theme=true
RNS Number : 4852C Feedback PLC 23 February 2022
Feedback plc
Grant of Options and PDMR dealing
London, 23 February 2022: Feedback plc (AIM: FDBK, "Feedback" or the
"Company"), the specialist clinical communication company, announces that it
has granted a total of 162,692,640 options to subscribe for new ordinary
shares in the Company under the Company's Non-tax-advantaged and EMI Share
Option Schemes (together, the "Options") to a certain number of its directors
and employees, as detailed below.
The Options are being issued to support staff retention and to further align
overall reward with increasing shareholder value.
All Options are exercisable at a price of 0.7 pence per share, reflecting the
price at which the Company last completed an equity fundraise in November 2021
and representing a premium of 3 per cent to the closing share price on the
last trading day before this announcement.
145,237,200 Options granted to the Executive Directors and other persons
discharging managerial responsibilities ("PDMRs") below (being 89 percent. of
Options granted) will vest in three equal tranches over the next three
financial years, conditional on achieving certain share price targets (based
on a 60 calendar day volume weighted average share price) as follows:
· One-third will vest if the share price reaches at least 1.20p,
during the period commencing 31/05/2022 and ending 31/05/2025;
· One-third will vest if the share price reaches at least 1.86p
during the period commencing 31/05/2023 and ending 31/05/2025; and
· One-third will vest if the share price reaches at least 3.0p
during the period commencing 31/05/2024 and ending 31/05/2025.
Options being granted to the Executive Directors and PDMRs which are subject
to the share price performance conditions above:
Non tax-Advantaged Options EMI Options Total options held (including existing options)
Tom Oakley, CEO 83,846,520 - 106,677,349
Anesh Patel, CFO 17,624,520 35,714,160 53,338,680
Michael Hayball, CTO - 2,013,000 9,213,000
Stephen Brown, Chief Regulatory & Compliance Officer - 2,013,000 9,213,000
Stephen McAteer, COO - 2,013,000 4,013,000
Nicolas Mayhew, Chief Sales & Marketing Officer - 2,013,000 4,013,000
7,855,440 EMI Options (with time-based vesting conditions only) were awarded
to 10 employees, with one-third vesting on each of the first, second and third
anniversaries of grant.
In addition, Rory Shaw, Non-Executive Chairman, has been granted 9,600,000 Non
tax-Advantaged Options (taking the total number of share options held by him
to 17,400,000), primarily for retention purposes. Alongside the Executive
management team, Rory has key relationships with NHS bodies and Community
Diagnostic Centres (CDC), potential customers for the Company's product suite.
These Options have time-based vesting conditions only and are not linked to
share price performance conditions, with one-third vesting on each of the
first, second and third anniversaries of grant.
The Options are exercisable for a period of 5 years from the vesting date.
The Options represent in aggregate 6.1% of the Company's existing issued share
capital.
Following the grant of the Options and taking into account existing options,
the Company has a total of 217,516,909 options to subscribe for ordinary
shares in the Company in issue, representing 8.2% of the Company's issued
share capital at the date of this announcement.
The FCA notifications, made in accordance with the requirements of the EU
Market Abuse Regulation, are appended below.
Further information on Feedback and its products can be found on the Company's
website: https://fbkmed.com/feedback-plc/reports-and-presentations/
(https://fbkmed.com/feedback-plc/reports-and-presentations/)
-Ends-
Enquiries:
Feedback plc +44 (0) 20 3997 7634
Tom Oakley, CEO IR@fbk.com (mailto:IR@fbk.com)
Anesh Patel, CFO
Panmure Gordon (UK) Limited (NOMAD and Broker) +44 (0)20 7886 2500
Emma Earl/Freddy Crossley (Corporate Finance)
Rupert Dearden (Corporate Broking)
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
(mailto:feedbackplc@walbrookpr.com)
Paul McManus/Nick Rome/Nicholas Johnson 07980 541 893 or 07748 325 236 or 07884 664 686
About Feedback
Feedback plc is a specialist clinical communications business, with a mission
to improve the efficiency and quality of communications for frontline
clinicians and hospitals with a key focus on building solutions that enhance
access to high quality patient data.
Feedback has developed a toolkit of clinical communications apps. Its core,
regulatory approved product is Bleepa, a revolutionary medical imaging app
enabling remote and secure communications between frontline clinicians and
teams. CareLocker is an evolutionary GDPR compliant patient-centric cloud
architecture - its proprietary technology enables an easy route to creation
and mobilisation of individual healthcare records. Bleepa Box is a specialist
tool to enable image transfer from remote settings to the Bleepa platform over
mobile networks.
The Company has a number of growth opportunities domestically and
internationally across a range of markets including the NHS, the veterinary
market and private healthcare providers and its highly scalable Software as a
Service ("SaaS")-based revenue model is expected to provide increasing levels
of visibility as the Company grows its customer base.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Rory Shaw
2 Reason for the notification
a) Position/status PDMR - Non-Executive Chairman
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Feedback plc
b) LEI 213800UGOF2GT2U2RV90
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Non-tax-advantaged Options to subscribe for Ordinary Shares of 0.25p each
Identification code
Identification code (ISIN) for Feedback plc ordinary shares:
GB0003340550
b) Nature of the transaction Issue of options to subscribe for Ordinary Shares in consideration of
payment of fees
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price of 0.7p 9,600,000 shares
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 23 February 2022
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
23 February 2022
f)
Place of the transaction
Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Tom Oakley
2 Reason for the notification
a) Position/status PDMR - Chief Executive Officer
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Feedback plc
b) LEI 213800UGOF2GT2U2RV90
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Non-tax-advantaged Options to subscribe for Ordinary Shares of 0.25p each
Identification code
Identification code (ISIN) for Feedback plc ordinary shares:
GB0003340550
b) Nature of the transaction Issue of options to subscribe for Ordinary Shares in consideration of
payment of fees
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price of 0.7p 83,846,520 shares
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 23 February 2022
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
23 February 2022
f)
Place of the transaction
Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Anesh Patel
2 Reason for the notification
a) Position/status PDMR - Chief Financial Officer
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Feedback plc
b) LEI 213800UGOF2GT2U2RV90
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Non-tax-advantaged Options and EMI Options to subscribe for Ordinary Shares of
0.25p each
Identification code
Identification code (ISIN) for Feedback plc ordinary shares:
GB0003340550
b) Nature of the transaction Issue of options to subscribe for Ordinary Shares in consideration of
payment of fees
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price of 0.7p 53,338,680 shares
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 23 February 2022
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
23 February 2022
f)
Place of the transaction
Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Michael Hayball
2 Reason for the notification
a) Position/status PDMR - Director of Feedback Medical Limited
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Feedback plc
b) LEI 213800UGOF2GT2U2RV90
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument EMI Options to subscribe for Ordinary Shares of 0.25p each
Identification code
Identification code (ISIN) for Feedback plc ordinary shares:
GB0003340550
b) Nature of the transaction Issue of options to subscribe for Ordinary Shares in consideration of
payment of fees
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price of 0.7p 2,013,000 shares
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 23 February 2022
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
23 February 2022
f)
Place of the transaction
Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Stephen McAteer
2 Reason for the notification
a) Position/status PDMR - Director of Feedback Medical Limited
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Feedback plc
b) LEI 213800UGOF2GT2U2RV90
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument EMI Options to subscribe for Ordinary Shares of 0.25p each
Identification code
Identification code (ISIN) for Feedback plc ordinary shares:
GB0003340550
b) Nature of the transaction Issue of options to subscribe for Ordinary Shares in consideration of
payment of fees
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price of 0.7p 2,013,000 shares
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 23 February 2022
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
23 February 2022
f)
Place of the transaction
Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Nicolas Mayhew
2 Reason for the notification
a) Position/status PDMR - Director of Feedback Medical Limited
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Feedback plc
b) LEI 213800UGOF2GT2U2RV90
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument EMI Options to subscribe for Ordinary Shares of 0.25p each
Identification code
Identification code (ISIN) for Feedback plc ordinary shares:
GB0003340550
b) Nature of the transaction Issue of options to subscribe for Ordinary Shares in consideration of
payment of fees
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price of 0.7p 2,013,000 shares
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 23 February 2022
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
23 February 2022
f)
Place of the transaction
Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Stephen Brown
2 Reason for the notification
a) Position/status PDMR - Director of Feedback Medical Limited
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Feedback plc
b) LEI 213800UGOF2GT2U2RV90
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument EMI Options to subscribe for Ordinary Shares of 0.25p each
Identification code
Identification code (ISIN) for Feedback plc ordinary shares:
GB0003340550
b) Nature of the transaction Issue of options to subscribe for Ordinary Shares in consideration of
payment of fees
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price of 0.7p 2,013,000 shares
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 23 February 2022
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
23 February 2022
f)
Place of the transaction
Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHVLLFLLLLFBBV